Q-linea Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Q-linea hat ein Gesamteigenkapital von SEK133.8M und eine Gesamtverschuldung von SEK0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen SEK174.1M bzw. SEK40.2M.

Wichtige Informationen

60.9%

Verhältnis von Schulden zu Eigenkapital

SEK 41.50m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	SEK 20.86m
Eigenkapital	SEK 68.11m
Gesamtverbindlichkeiten	SEK 90.87m
Gesamtvermögen	SEK 158.97m

Jüngste Berichte zur Finanzlage

Recent updates

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Dec 31

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

May 07

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Jan 11

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

Feb 17

Do Institutions Own Q-linea AB (publ) (STO:QLINEA) Shares?

Dec 26

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: QLINEADie kurzfristigen Aktiva des Unternehmens (SEK113.5M) übersteigen seine kurzfristigen Passiva (SEK30.6M).

Langfristige Verbindlichkeiten: QLINEADie kurzfristigen Vermögenswerte des Unternehmens (SEK113.5M) übersteigen seine langfristigen Verbindlichkeiten (SEK9.6M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: QLINEADie Nettoverschuldung im Verhältnis zum Eigenkapital (30.3%) wird als zufriedenstellend angesehen.

Schulden abbauen: QLINEADas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0.2% auf 60.9% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: QLINEA hat auf der Grundlage seines derzeitigen freier Cashflows weniger als ein Jahr Liquiditätsspielraum.

Vorhersage Cash Runway: QLINEA hat weniger als ein Jahr Liquiditätsreserven, wenn der freie Cashflow weiterhin mit den historischen Raten von 16.3% pro Jahr abnimmt

Q-linea Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

Recent updates

Consensus revenue estimates fall by 42%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Q-linea AB (publ) to Report Q1, 2025 Results on May 03, 2025

Q-linea AB (publ) Approves the Election of Jonas Jarvius as Members of the Board of Directors

Consensus revenue estimates increase by 49%

First quarter 2024 earnings released: kr0.48 loss per share (vs kr2.10 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates increase by 24%, EPS downgraded

New minor risk - Profitability

No longer forecast to breakeven

Full year 2023 earnings: EPS and revenues miss analyst expectations

Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024

Q-linea AB (publ) Announces CEO Changes

Q-linea AB (publ) to Report First Half, 2024 Results on Jul 11, 2024

Q-linea AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024

Here's Why Q-linea (STO:QLINEA) Must Use Its Cash Wisely

Forecast to breakeven in 2026

Consensus revenue estimates decrease by 27%

Price target decreased by 13% to kr10.00

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Q-Linea AB (Publ) Announces Jonas Jarvius to Step Down as CEO Before Summer 2024

Q-linea AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 262.885275 million.

New major risk - Share price stability

Consensus revenue estimates decrease by 40%, EPS upgraded

Q-linea AB (publ) Completes its 510(k) Application for US Market Approval

Second quarter 2023 earnings released: kr2.23 loss per share (vs kr2.53 loss in 2Q 2022)

Q-linea AB (publ) Announces First Patient Enrolls in Lifetimes

Consensus revenue estimates increase by 40%, EPS downgraded

Insufficient new directors

Full year 2022 earnings: EPS and revenues miss analyst expectations

CFO & Investor Relations Officer recently bought kr143k worth of stock

Full year 2022 earnings released: kr9.20 loss per share (vs kr8.19 loss in FY 2021)

Q-linea AB (publ) Announces CFO Changes, Effective May 1, 2023

Q-linea AB (publ) Prepare to Start Additional Testing for US 510(K) Application

Q-Linea Participates in Comparative Rapid AST Study

VP & Research Director recently bought kr241k worth of stock

Consensus revenue estimates fall by 21%

Q-linea AB (publ) to Report Q1, 2023 Results on May 04, 2023

Third quarter 2022 earnings released: kr2.03 loss per share (vs kr1.68 loss in 3Q 2021)

Consensus revenue estimates fall by 34%

Second quarter 2022 earnings released: kr2.53 loss per share (vs kr2.47 loss in 2Q 2021)

Consensus revenue estimates fall by 82%

Will Q-linea (STO:QLINEA) Spend Its Cash Wisely?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 22% undervalued after recent price drop

Price target decreased to kr165

Q-linea AB (publ) Announces Marcus Storch Not Available for Re-Election as Member of Board of Directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

CEO & President recently bought kr480k worth of stock

Insufficient new directors

Now 22% undervalued after recent price drop

Price target decreased to kr165

Forecast breakeven date pushed back to 2024

Full year 2021 earnings: EPS and revenues miss analyst expectations

Q-linea (STO:QLINEA) Is In A Good Position To Deliver On Growth Plans

Forecast to breakeven in 2023

Third quarter 2021 earnings released: kr1.68 loss per share (vs kr1.80 loss in 3Q 2020)

Forecast to breakeven in 2023

Second quarter 2021 earnings released: kr2.47 loss per share (vs kr2.37 loss in 2Q 2020)

CEO & President recently sold kr14m worth of stock

Q-linea AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 301.4 million.

Q-linea AB (publ) Initiates US 510(k) Clinical Study for ASTar

Consensus forecasts updated

First quarter 2021 earnings released: kr2.34 loss per share (vs kr2.44 loss in 1Q 2020)

Full year 2020 earnings released: kr8.64 loss per share (vs kr7.74 loss in FY 2019)

Price target increased to kr185

Q-linea AB (publ) Receives First Order on ASTar

Full year 2020 earnings released: kr8.64 loss per share (vs kr7.74 loss in FY 2019)

Revenue beats expectations

We're Hopeful That Q-linea (STO:QLINEA) Will Use Its Cash Wisely

New 90-day low: kr150